Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus.

Li, Fang; Lei, Feifei; Wen, Chengcai; Ge, Qiu; Zhu, Liyao

Li, Fang; Lei, Feifei; Wen, Chengcai; Ge, Qiu; Zhu, Liyao.

Afiliación

Li F; Department of Infectious Diseases, Institute of Hepatic Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, China.
Lei F; Department of Infectious Diseases, Institute of Hepatic Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, China.
Wen C; Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Ge Q; Outpatient Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China. gq319329@163.com.
Zhu L; Department of Hepatology, The Fourth People's Hospital of Huai'an, Jiangsu, China. zhu_liyao@126.com.

BMC Gastroenterol ; 21(1): 391, 2021 Oct 20.

Article en En | MEDLINE | ID: mdl-34670509

Asunto(s)

Diabetes Mellitus Tipo 2; Hepatitis C; Queratina-18/metabolismo; Diabetes Mellitus Tipo 2/complicaciones; Hepacivirus; Humanos; Cirrosis Hepática/diagnóstico; Estudios Retrospectivos

Palabras clave

Cytokeratin 18 (CK18); Hepatitis C virus (HCV); Liver fibrosis; Predictive values; Type 2 diabetes mellitus (T2DM)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hepatitis C / Diabetes Mellitus Tipo 2 / Queratina-18 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google